Return to News

COSMIC News

top mutations

Join our team

15 Jun 2017

We seek a talented and highly motivated post-doctoral scientist to lead new research on cancer mutations in the COSMIC team at the Sanger Institute, Cambridge, UK.

We are using bioinformatic techniques to characterise every genetic mutation across all forms of cancer, to define and understand the important genetic events which are creating disease. Ultimately, this is intended to identify and describe new targets for precision medicine development.

In this position you will take a leading scientific role in a new project aiming to describe every cancer mutation across multiple biological properties. We aim to take a very broad approach across millions of variants and hundreds of cancer disease types, to identify which variants act as drivers of disease, then correlate how they work together to cause disease. You will have the opportunity to characterise the biological features of every mutation in cancer, defining what might make them drive cancer. You will be aiming to compose a unique set of bioinformatic resources, generated from existing systems and databases, as well as new ones created by you, to identify key features across somatic cancer variation, primarily focused on annotating the COSMIC database.

Working in the COSMIC team, the world’s largest and most detailed database of cancer mutations will be available to you. Within the broader Sanger Institute, you will have access to global specialists in genomics with decades of experience discovering new disease genes. In addition, this information is vital for use in pharmaceutical and clinical applications, so we have partnered with AstraZeneca on this project, working closely with their Oncology division; your research will therefore impact directly on the discovery and development of new precision medicines.

We anticipate this project will create a major new resource to discover and understand new targets in cancer genetics, and your research can ultimately have an impact on the clinical treatment of cancer patients when they reach hospital. You will also have substantial opportunities to learn more about precision oncology, and how pharmaceutical development works. We also anticipate several high-impact publication opportunities from the research you drive, focused around data annotation and exploration, biomarker discovery along with novel bioinformatic methods you may develop. 

For further details and to apply see the Sanger website

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations

IWD24

Women in STEM

IT

computational biology

STEM career

computer science

v100

cancer mutation census

genetic oncology